Cargando…
The influence of genomics and proteomics on the development of potential vaccines against meningococcal infection
There is a particular need for an effective vaccine against life-threatening meningitis and septicemia caused by Neisseria meningitidis (meningococcus) serogroup B strains. Vaccine strategies incorporating capsular polysaccharide have proved effective against other meningococcal serogroups, but are...
Autores principales: | Heckels, John E, Williams, Jeannette N |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923735/ https://www.ncbi.nlm.nih.gov/pubmed/20670394 http://dx.doi.org/10.1186/gm164 |
Ejemplares similares
-
Vaccines against Meningococcal Diseases
por: Pizza, Mariagrazia, et al.
Publicado: (2020) -
The Adhesin Complex Protein (ACP) of Neisseria meningitidis Is a New Adhesin with Vaccine Potential
por: Hung, Miao-Chiu, et al.
Publicado: (2013) -
Control of meningococcal meningitis with meningococcal vaccines.
por: Artenstein, M. S.
Publicado: (1975) -
Meningococcal Vaccinations
por: Crum-Cianflone, Nancy, et al.
Publicado: (2016) -
Impact of COVID-19 pandemic on vaccination against meningococcal C infection in Brazil
por: da Silva, Thales Philipe Rodrigues, et al.
Publicado: (2022)